CN1100949A - 金樱保健系列产品及其制法 - Google Patents
金樱保健系列产品及其制法 Download PDFInfo
- Publication number
- CN1100949A CN1100949A CN 94102409 CN94102409A CN1100949A CN 1100949 A CN1100949 A CN 1100949A CN 94102409 CN94102409 CN 94102409 CN 94102409 A CN94102409 A CN 94102409A CN 1100949 A CN1100949 A CN 1100949A
- Authority
- CN
- China
- Prior art keywords
- health
- grams
- medicated powder
- care
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 8
- 235000000661 Rosa laevigata Nutrition 0.000 title abstract description 5
- 241001278833 Rosa laevigata Species 0.000 title abstract description 5
- 239000000843 powder Substances 0.000 claims abstract description 30
- 239000000463 material Substances 0.000 claims abstract description 24
- 235000014101 wine Nutrition 0.000 claims abstract description 17
- 235000013361 beverage Nutrition 0.000 claims abstract description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 19
- 230000001954 sterilising effect Effects 0.000 claims description 15
- 238000004659 sterilization and disinfection Methods 0.000 claims description 15
- 238000000855 fermentation Methods 0.000 claims description 13
- 230000004151 fermentation Effects 0.000 claims description 13
- 241000209051 Saccharum Species 0.000 claims description 10
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 9
- 239000000600 sorbitol Substances 0.000 claims description 9
- 241000287828 Gallus gallus Species 0.000 claims description 8
- 241000180649 Panax notoginseng Species 0.000 claims description 8
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 8
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 7
- 229930006000 Sucrose Natural products 0.000 claims description 7
- 235000015165 citric acid Nutrition 0.000 claims description 7
- 239000012153 distilled water Substances 0.000 claims description 7
- 235000019991 rice wine Nutrition 0.000 claims description 7
- 241000628997 Flos Species 0.000 claims description 6
- 239000009636 Huang Qi Substances 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 6
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 6
- 210000002826 placenta Anatomy 0.000 claims description 6
- 235000018553 tannin Nutrition 0.000 claims description 6
- 239000001648 tannin Substances 0.000 claims description 6
- 229920001864 tannin Polymers 0.000 claims description 6
- 241000282376 Panthera tigris Species 0.000 claims description 5
- 229920002472 Starch Polymers 0.000 claims description 5
- 235000021551 crystal sugar Nutrition 0.000 claims description 5
- 210000003038 endothelium Anatomy 0.000 claims description 5
- 238000005516 engineering process Methods 0.000 claims description 5
- 239000008107 starch Substances 0.000 claims description 5
- 235000019698 starch Nutrition 0.000 claims description 5
- 210000001550 testis Anatomy 0.000 claims description 5
- 241000282465 Canis Species 0.000 claims description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 4
- 239000006071 cream Substances 0.000 claims description 4
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 2
- 235000013399 edible fruits Nutrition 0.000 abstract description 16
- 230000036541 health Effects 0.000 abstract description 10
- 150000001413 amino acids Chemical class 0.000 abstract description 8
- 241000196324 Embryophyta Species 0.000 abstract description 7
- 241001465754 Metazoa Species 0.000 abstract description 7
- 241000411851 herbal medicine Species 0.000 abstract description 7
- 239000011573 trace mineral Substances 0.000 abstract description 5
- 235000013619 trace mineral Nutrition 0.000 abstract description 5
- 238000004458 analytical method Methods 0.000 abstract description 4
- 235000013305 food Nutrition 0.000 abstract description 4
- 239000007788 liquid Substances 0.000 abstract description 4
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 abstract description 2
- 238000011047 acute toxicity test Methods 0.000 abstract description 2
- 150000001875 compounds Chemical class 0.000 abstract description 2
- 238000007689 inspection Methods 0.000 abstract description 2
- 231100000252 nontoxic Toxicity 0.000 abstract description 2
- 230000003000 nontoxic effect Effects 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 230000032683 aging Effects 0.000 abstract 1
- 230000006806 disease prevention Effects 0.000 abstract 1
- 235000015097 nutrients Nutrition 0.000 abstract 1
- 230000009471 action Effects 0.000 description 15
- 235000009508 confectionery Nutrition 0.000 description 14
- 239000000470 constituent Substances 0.000 description 12
- 239000000126 substance Substances 0.000 description 12
- 230000000694 effects Effects 0.000 description 10
- 210000003734 kidney Anatomy 0.000 description 10
- 208000002193 Pain Diseases 0.000 description 9
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 239000002253 acid Substances 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 6
- 208000001848 dysentery Diseases 0.000 description 6
- 210000003205 muscle Anatomy 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 206010003549 asthenia Diseases 0.000 description 5
- 229960001231 choline Drugs 0.000 description 5
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- 241000282472 Canis lupus familiaris Species 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- 241001501970 Prionailurus bengalensis Species 0.000 description 4
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- -1 bark is resinous Polymers 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 201000006549 dyspepsia Diseases 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 4
- 239000001630 malic acid Substances 0.000 description 4
- 235000011090 malic acid Nutrition 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 230000001603 reducing effect Effects 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 208000007443 Neurasthenia Diseases 0.000 description 3
- 102000003992 Peroxidases Human genes 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 244000126002 Ziziphus vulgaris Species 0.000 description 3
- 235000006533 astragalus Nutrition 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 230000008602 contraction Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 150000002338 glycosides Chemical class 0.000 description 3
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 3
- 229960004949 glycyrrhizic acid Drugs 0.000 description 3
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 3
- 235000019410 glycyrrhizin Nutrition 0.000 description 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 206010029410 night sweats Diseases 0.000 description 3
- 230000036565 night sweats Effects 0.000 description 3
- 108040007629 peroxidase activity proteins Proteins 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 2
- DANYIYRPLHHOCZ-UHFFFAOYSA-N 5,7-dihydroxy-4'-methoxyflavone Chemical compound C1=CC(OC)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 DANYIYRPLHHOCZ-UHFFFAOYSA-N 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
- 229930024421 Adenine Natural products 0.000 description 2
- 241000045403 Astragalus propinquus Species 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- DHHFDKNIEVKVKS-FMOSSLLZSA-N Betanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC(C[C@H]2C([O-])=O)=C1[N+]2=C\C=C\1C=C(C(O)=O)N[C@H](C(O)=O)C/1 DHHFDKNIEVKVKS-FMOSSLLZSA-N 0.000 description 2
- DHHFDKNIEVKVKS-MVUYWVKGSA-N Betanin Natural products O=C(O)[C@@H]1NC(C(=O)O)=C/C(=C\C=[N+]/2\[C@@H](C(=O)[O-])Cc3c\2cc(O)c(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)c3)/C1 DHHFDKNIEVKVKS-MVUYWVKGSA-N 0.000 description 2
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 2
- 240000006432 Carica papaya Species 0.000 description 2
- 235000009467 Carica papaya Nutrition 0.000 description 2
- 240000000425 Chaenomeles speciosa Species 0.000 description 2
- 235000005078 Chaenomeles speciosa Nutrition 0.000 description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 2
- 208000004232 Enteritis Diseases 0.000 description 2
- 208000008967 Enuresis Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 208000010228 Erectile Dysfunction Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 2
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 2
- 239000004378 Glycyrrhizin Substances 0.000 description 2
- 239000000899 Gutta-Percha Substances 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000015817 Infant Nutrition disease Diseases 0.000 description 2
- CMUNUTVVOOHQPW-LURJTMIESA-N L-proline betaine Chemical compound C[N+]1(C)CCC[C@H]1C([O-])=O CMUNUTVVOOHQPW-LURJTMIESA-N 0.000 description 2
- 244000241838 Lycium barbarum Species 0.000 description 2
- 206010050031 Muscle strain Diseases 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 2
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 2
- 206010029216 Nervousness Diseases 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- 240000000342 Palaquium gutta Species 0.000 description 2
- 244000131316 Panax pseudoginseng Species 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- QMQIQBOGXYYATH-IDABPMKMSA-N Ruscogenin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)[C@H](O)C[C@H](O)CC4=CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 QMQIQBOGXYYATH-IDABPMKMSA-N 0.000 description 2
- BSUPFYRQXCQGLJ-UHFFFAOYSA-N Ruscogenin Natural products CC1CCC2(OC1)OC3C(O)C4C5CC=C6CC(O)CC(O)C6(C)C5CCC4(C)C3C2C BSUPFYRQXCQGLJ-UHFFFAOYSA-N 0.000 description 2
- 241000612118 Samolus valerandi Species 0.000 description 2
- 206010039897 Sedation Diseases 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 102000003425 Tyrosinase Human genes 0.000 description 2
- 108060008724 Tyrosinase Proteins 0.000 description 2
- 206010046814 Uterine prolapse Diseases 0.000 description 2
- 235000008529 Ziziphus vulgaris Nutrition 0.000 description 2
- 229960000643 adenine Drugs 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- RJWJHRPNHPHBRN-FKVJWERZSA-N aucubin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@@H]2C(CO)=C[C@@H](O)[C@@H]2C=CO1 RJWJHRPNHPHBRN-FKVJWERZSA-N 0.000 description 2
- UTDFQMAXCUGNJR-UHFFFAOYSA-N aucubin Natural products OCC1OC(Oc2ccoc2C3C(O)CCC3O)C(O)C(O)C1O UTDFQMAXCUGNJR-UHFFFAOYSA-N 0.000 description 2
- 239000001654 beetroot red Substances 0.000 description 2
- 235000012677 beetroot red Nutrition 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 235000002185 betanin Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 229940074393 chlorogenic acid Drugs 0.000 description 2
- 235000001368 chlorogenic acid Nutrition 0.000 description 2
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 2
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 2
- 239000003218 coronary vasodilator agent Substances 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 229960003720 enoxolone Drugs 0.000 description 2
- QMQIQBOGXYYATH-UHFFFAOYSA-N epiruscogenin Natural products CC1C(C2(CCC3C4(C)C(O)CC(O)CC4=CCC3C2C2)C)C2OC11CCC(C)CO1 QMQIQBOGXYYATH-UHFFFAOYSA-N 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000012041 food component Nutrition 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 210000004317 gizzard Anatomy 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 229920000588 gutta-percha Polymers 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000002949 hemolytic effect Effects 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 235000008777 kaempferol Nutrition 0.000 description 2
- GBRZTUJCDFSIHM-KRWDZBQOSA-N licoricidin Chemical compound C1([C@@H]2COC=3C=C(O)C(CC=C(C)C)=C(C=3C2)OC)=CC=C(O)C(CC=C(C)C)=C1O GBRZTUJCDFSIHM-KRWDZBQOSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 229940109990 ruscogenin Drugs 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000036280 sedation Effects 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- CMUNUTVVOOHQPW-ZCFIWIBFSA-N stachydrine Natural products C[N+]1(C)CCC[C@@H]1C([O-])=O CMUNUTVVOOHQPW-ZCFIWIBFSA-N 0.000 description 2
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- 150000008130 triterpenoid saponins Chemical class 0.000 description 2
- JLTCWSBVQSZVLT-CDIPANDDSA-N (2s)-n-[(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosan Chemical compound NCCCC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](N)CSSC1.C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 JLTCWSBVQSZVLT-CDIPANDDSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- QGJZLNKBHJESQX-UHFFFAOYSA-N 3-Epi-Betulin-Saeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(=C)C)C5C4CCC3C21C QGJZLNKBHJESQX-UHFFFAOYSA-N 0.000 description 1
- CLOUCVRNYSHRCF-UHFFFAOYSA-N 3beta-Hydroxy-20(29)-Lupen-3,27-oic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C(O)=O)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C CLOUCVRNYSHRCF-UHFFFAOYSA-N 0.000 description 1
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-M 9-cis,12-cis-Octadecadienoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC([O-])=O OYHQOLUKZRVURQ-HZJYTTRNSA-M 0.000 description 1
- 241001580935 Aglossa pinguinalis Species 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 235000006264 Asimina triloba Nutrition 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- 241000266855 Astragalus mongholicus Species 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- DIZWSDNSTNAYHK-XGWVBXMLSA-N Betulinic acid Natural products CC(=C)[C@@H]1C[C@H]([C@H]2CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O DIZWSDNSTNAYHK-XGWVBXMLSA-N 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 206010065559 Cerebral arteriosclerosis Diseases 0.000 description 1
- 241001507936 Chaenomeles Species 0.000 description 1
- 208000010445 Chilblains Diseases 0.000 description 1
- 102000011022 Chorionic Gonadotropin Human genes 0.000 description 1
- 108010062540 Chorionic Gonadotropin Proteins 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 235000009604 Chrysanthemum X morifolium Nutrition 0.000 description 1
- 206010009168 Chyluria Diseases 0.000 description 1
- 241000193449 Clostridium tetani Species 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 241001092040 Crataegus Species 0.000 description 1
- 235000017159 Crataegus pinnatifida Nutrition 0.000 description 1
- 241000657480 Crataegus pinnatifida Species 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 208000006558 Dental Calculus Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000208686 Eucommiaceae Species 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- PVKQULHHWVQXLE-UHFFFAOYSA-N Glycyrol Natural products C12=CC=C(O)C=C2OC2=C1C(=O)OC1=C2C(O)=C(CC=C(C)C)C(OC)=C1 PVKQULHHWVQXLE-UHFFFAOYSA-N 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 241000594394 Hedyotis Species 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- GFJNBLOMWYSKSS-UHFFFAOYSA-N Isoglycyrol Natural products COc1c2CCC(C)(C)Oc2cc3OC(=O)c4c(oc5c(O)cccc45)c13 GFJNBLOMWYSKSS-UHFFFAOYSA-N 0.000 description 1
- YNWXJFQOCHMPCK-UHFFFAOYSA-N Isoliquiritin Natural products OC1C(O)C(O)C(CO)OC1OC(C=C1)=CC=C1C=CC(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-UHFFFAOYSA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 241000589902 Leptospira Species 0.000 description 1
- DUKURNFHYQXCJG-UHFFFAOYSA-N Lewis A pentasaccharide Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(C)=O)C(OC2C(C(OC3C(OC(O)C(O)C3O)CO)OC(CO)C2O)O)OC1CO DUKURNFHYQXCJG-UHFFFAOYSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- MVAUGMLUJKTORM-UHFFFAOYSA-N Licoricidin Natural products COc1cc2OCC(Cc2cc1CC=C(C)C)c3ccc(O)c(CC=C(C)C)c3O MVAUGMLUJKTORM-UHFFFAOYSA-N 0.000 description 1
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 1
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 244000241872 Lycium chinense Species 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 206010051458 Myometritis Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 description 1
- QFJUYMMIBFBOJY-UXZRXANASA-N Panaxatriol Chemical compound C[C@]1([C@H]2CC[C@@]3([C@@H]2[C@H](O)C[C@H]2[C@]3(C[C@@H](O)[C@H]3C(C)(C)[C@@H](O)CC[C@@]32C)C)C)CCCC(C)(C)O1 QFJUYMMIBFBOJY-UXZRXANASA-N 0.000 description 1
- VIXIMKLMEZTTTC-UHFFFAOYSA-N Panaxatriol Natural products CC1(C)CCCC(O1)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5C(O)CC34C VIXIMKLMEZTTTC-UHFFFAOYSA-N 0.000 description 1
- 241000282373 Panthera pardus Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- XACHQDDXHDTRLX-XLVVAOPESA-N Physalien Chemical compound CC1(C)C[C@H](OC(=O)CCCCCCCCCCCCCCC)CC(C)=C1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C[C@@H](OC(=O)CCCCCCCCCCCCCCC)CC1(C)C XACHQDDXHDTRLX-XLVVAOPESA-N 0.000 description 1
- XACHQDDXHDTRLX-GMPBGBGESA-N Physalien Natural products O=C(O[C@H]1CC(C)(C)C(/C=C/C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/C=2C(C)(C)C[C@H](OC(=O)CCCCCCCCCCCCCCC)CC=2C)\C)/C)\C)/C)=C(C)C1)CCCCCCCCCCCCCCC XACHQDDXHDTRLX-GMPBGBGESA-N 0.000 description 1
- 244000064622 Physalis edulis Species 0.000 description 1
- 241000722363 Piper Species 0.000 description 1
- 241000886617 Piper boehmeriifolium Species 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 102000005320 Posterior Pituitary Hormones Human genes 0.000 description 1
- 108010070873 Posterior Pituitary Hormones Proteins 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 241000219100 Rhamnaceae Species 0.000 description 1
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 206010043561 Thrombocytopenic purpura Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- LRFVTYWOQMYALW-UHFFFAOYSA-N Xanthine Natural products O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 1
- XACHQDDXHDTRLX-UHFFFAOYSA-N Zeaxanthin-dipalmitat Natural products CC1(C)CC(OC(=O)CCCCCCCCCCCCCCC)CC(C)=C1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)CC(OC(=O)CCCCCCCCCCCCCCC)CC1(C)C XACHQDDXHDTRLX-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 235000009962 acacetin Nutrition 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000002804 anti-anaphylactic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- QGJZLNKBHJESQX-FZFNOLFKSA-N betulinic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C QGJZLNKBHJESQX-FZFNOLFKSA-N 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940015047 chorionic gonadotropin Drugs 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- MDZKJHQSJHYOHJ-UHFFFAOYSA-N crataegolic acid Natural products C1C(O)C(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MDZKJHQSJHYOHJ-UHFFFAOYSA-N 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000035613 defoliation Effects 0.000 description 1
- PZXJOHSZQAEJFE-UHFFFAOYSA-N dihydrobetulinic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(C)C)C5C4CCC3C21C PZXJOHSZQAEJFE-UHFFFAOYSA-N 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- LWESBHWAOZORCQ-UHFFFAOYSA-N glycyrol Chemical compound C12=CC=C(O)C=C2OC2=C1C(=O)OC1=C2C(OC)=C(CC=C(C)C)C(O)=C1 LWESBHWAOZORCQ-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 244000237330 gutta percha tree Species 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 201000005851 intracranial arteriosclerosis Diseases 0.000 description 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- CFWLRXJPRRCJTI-UHFFFAOYSA-N iso-glycyrol Chemical compound C12=CC=C(O)C=C2OC2=C1C(=O)OC1=C2C(OC)=C(CCC(C)(C)O2)C2=C1 CFWLRXJPRRCJTI-UHFFFAOYSA-N 0.000 description 1
- YNWXJFQOCHMPCK-LXGDFETPSA-N isoliquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-LXGDFETPSA-N 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- GBRZTUJCDFSIHM-UHFFFAOYSA-N licorisoflavan B Natural products C1C=2C(OC)=C(CC=C(C)C)C(O)=CC=2OCC1C1=CC=C(O)C(CC=C(C)C)=C1O GBRZTUJCDFSIHM-UHFFFAOYSA-N 0.000 description 1
- 229940049918 linoleate Drugs 0.000 description 1
- 230000002366 lipolytic effect Effects 0.000 description 1
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- MDZKJHQSJHYOHJ-LLICELPBSA-N maslinic acid Chemical compound C1[C@@H](O)[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MDZKJHQSJHYOHJ-LLICELPBSA-N 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- MQYXUWHLBZFQQO-UHFFFAOYSA-N nepehinol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C MQYXUWHLBZFQQO-UHFFFAOYSA-N 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000001734 parasympathetic effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000004999 sex organ Anatomy 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 230000008326 skin blood flow Effects 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 208000004441 taeniasis Diseases 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000008359 toxicosis Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 230000009978 visual deterioration Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 235000020338 yellow tea Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明属金樱保健系列产品及其制法,它是用金
樱子等十五种纯天然植、动物中草药为主要配方原
料,经生产健身酒、液、和保健饮料、膏、速溶冲剂的工
艺而制得金樱健身酒、液、和保健饮料、膏、速溶冲剂
系列产品。
本发明采用纯天然植、动物中草药为主要配方原
料,不含人工合成化合物,所制成的金樱保健系列产
品,富含多种营养成分、18种氨基酸、多种微量元素
及SOD,有保健、抗衰、益寿延年、防病、治病的作用,
经食品卫生部门作急性毒性试验属实际无毒级,食品
卫生检验符合GB2757—81标准;分析测试部门分
析含18种氨基酸、多种微量元素及SOD;医院临床
统计,总有效率91.67%,是适合男女老少的理想保
健品。
Description
本发明涉及保健品领域,特别是金樱保健系列产品及其制法。它是采用金樱子等十五种纯天然植、动物中草药为主要原料,经生产健身酒、液、和保健饮料、膏、速溶冲剂的工艺而制成金樱保健系列产品。
目前,已知有各种保健品很多,如:金樱子酒,是传统补肝助阳法,饮后上头,其他类似的保健品,作用、效能单一。利用金樱子等十多种纯天然植、动物中草药为配方原料,制成金樱保健系列产品尚未发现。
本发明的任务是综合各武家强身方、宫廷秘方、壮族民间健身延年补方及多年临床经验,经过现代的工艺模拟试验、研究而提供金樱保健系列产品及其制法。由于本发明的配方原料是纯天然植、动物中草药、所制得金樱保健系列产品,含有多种营养成分、氨基酸、微量元素,药物配伍、成分在于科学的固肾法,因此,具有保健、强身、抗衰、益寿延年、防病、治病的作用。
本发明的任务是这样完成的:
一、本发明的配方原料主要由如下十五种纯天然植、动物中草药组成:
1.金樱子,别名:糖罐子、刺头、倒挂金钩、黄茶瓶,为蔷薇属植物金樱子(Rosa Laevigata Michx.,)以果实、叶和根入药,是常绿攀援灌木,生于山崖石隙及阳坡灌丛等处,分布于华东、中南、西南及陕西等地,其化学成分:果实含维生素C、苹果酸、枸橼酸、鞣质、糖分、树脂、皂甙等;性味功能:果,甘、酸、平、补肾固精,叶,苦、平,解毒消肿,根,甘、淡、平,活血散瘀、祛风除湿、解毒收敛、杀虫;药理:果实口服既能促进胃液分泌帮助消化,又能使肠粘膜收缩、分泌减少而能止泻,抑菌:煎液对金黄色葡萄球菌、大肠杆菌、绿脓杆菌、痢疾杆菌及钩端螺旋体、破伤风杆菌均有抑制作用;主治:果可治性神经衰弱、高血压病、神经性头痛、久咳、自汗、盗汗、脾虚泄泻,慢性肾炎、遗精、遗尿、尿频、白带、崩漏疾患,叶外用治疮疖、烧烫伤、外伤出血,根治肠炎、痢疾、肾孟肾炎、乳糜尿、象皮肿、跌打损伤、腰肌劳损、风温关节痛、遗精、月经不调、白带、子宫脱垂、脱肛、外用治烧烫伤等症。
2.黄芪,别名:绵芪、绵黄芪,为豆科黄芪属植物膜荚黄芪[Astragalus membranaceus(Fisch)Bunge]及内蒙古黄芪(Astragalus mongholicus Bunge)的根,是多年生草本,生于山坡灌丛及旱坡砂质土壤地区,分布于黑龙江、吉林、辽宁、河北、山西、内蒙古、陕西、甘肃、宁夏、青海、山东、四川和西藏等省区,其化学成分:根含2′,4′二羟基-5,6-二甲氧基异黄酮(2′,4′-dihydroxy-5,6-dimethoxy-isoflavone)、胆碱(choline)、甜菜碱(betaine)、氨基酸、蔗糖、葡萄糖醛酸及微量的叶酸;性味功能:甘、微温,补气固表,托疮生肌;药理:能加强正常心脏收缩,对衰竭的心脏有强心作用,能使冠状血管、肾脏、全身末梢血管扩张,皮肤血循环畅盛,高血压患者血压下降及有中等利尿作用,抑菌:在体外对志贺氏痢疾杆菌、炭疽杆菌、甲型溶血性链球菌、乙型溶血性链球菌、白喉杆菌、肺炎双球菌、金黄色葡萄球菌、柠檬色葡萄球菌、枯草杆菌均有抑制作用;主治:体虚自汗、久泻、脱肛、子宫脱垂、慢性肾炎、体虚浮肿、慢性溃疡、疮口久不愈口。
3.杜促,别名:扯丝皮、思仲、丝棉皮、玉丝皮,为杜仲科杜仲属植物杜仲(Eucommia ulmoides Oliv)的干燥树皮,是落叶乔木,生于较温暖地区,分布于陕西、甘肃、浙江、江西、河南、湖南、广西、广东、四川、贵州、云南等省区,其化学成分:全株植物均含桃叶珊瑚甙(aucubin)及杜仲胶(gutta-percha),树皮含树脂,鞣质,叶含山柰醇(Kaempferol)、咖啡酸、绿原酸(chlorogenic acid)、酒石酸及还原糖,种子含大量脂肪油,主要为亚油酸酯;性味功能:甘、微辛、温,补肝肾、强筋骨,安胎;药理:有降压、呼吸兴奋、利尿,对动脉粥样硬化心冠状血管的收缩、镇静作用;主治:高血压病、头晕目眩、腰膝酸痛、筋骨痿软、肾虚尿频、妊娠胎漏、胎动不安。
4.枸杞子,为茄科枸杞属植物宁夏枸杞(Lycium barbarum L.)或枸杞(Lycium chinense mill)的果实,是灌木,多生于潮湿、强日照、土层深厚的黄土沟岸及山坡,分布于山西、内蒙古、陕西、甘肃、青海、宁夏、新疆等省区,野生和栽培均有,其化学成分:果实含甜菜碱(betaine,C5H11O2N)约0.1%,果皮含酸浆红素(physalien,C72H116O4为棕榈酸玉蜀黍黄质酯),还含微量胡萝卜素、硫胺、核黄素、菸酸及维生素C;性味功能:甘、平,滋补肝肾、益精明目;药理:有降低血糖的作用,能显著增加血清及肝的磷脂含量,对中枢性及末梢性的副交感神经有兴奋作用,有降胆固醇作用及轻微抗动脉粥样硬化形成的作用;主治:肾虚精血不足,腰脊酸痛、性神经衰弱、头目眩晕、视力减退。
5.木瓜,别名:贴梗海棠、铁脚梨、皱皮木瓜、宣木瓜,为蔷薇科木瓜属贴梗木瓜(chaenomeles lagenaria)的果实,是落叶灌木,生于向阳、肥沃的土地,分布于南方、在河北、陕西、山东、江苏、安徽、浙江、江西、福建、河南、湖北、湖南、广东、四川和云南等地,其化学成分:果实含皂甙、黄酮类、维生素C和苹果酸、酒石酸、枸橼酸,大量有机酸,还含过氧化酶(catalase)、过氧化物酶(peroxidase)、酚氧化酶(phenol oxidase)、氧化酶(oxidase)、鞣质、果胶等;性味功能:酸、涩、温,舒筋活络、和胃化湿;主治:腰腿酸痛、麻木、吐泻腹痛、腓肠肌疼挛四肢抽搐。
6.山楂,别名:红果子、棠棣子,为蔷薇科山楂属植物山楂(Crataegus pinnatifida Bunge)的果实,根和叶也可入药,是落叶小乔木,生于山坡砂地、河边杂林,北方常有栽培,分布于东北、华北、西北和山东、江苏、河南等地,其化学成分:果实含山楂酸(Crataegic acid,C30H48O4)、酒名酸、枸橼酸、黄酮类、内酯、甙类、解脂酶及糖类;性味功能:甘、酸、温,消食化滞、散瘀止痛;药理:能增加胃中酶类分泌、促进消化、久服有降胆固醇的作用,抑菌:在体外对痢疾杆菌有较强的抑制作用;主治:果治肉食积滞、消化不良、小儿疳积、细菌性痢疾、肠炎、产后腹痛、高血压病、绦虫病、冻疮,叶煎水当茶饮,可降血压,根治风湿关节病、痢疾、水肿。
7.大枣,又名:红枣、枣子,为鼠李科枣属植物枣[Zizyphus Jujuba Mill.Var.inermis(Bunge)Rehd]的果实,其根及树皮亦入药,是落叶灌木或小乔木,全国各地均有栽培,其化学成分:果实含蛋白质、糖类、有机酸(苹果酸、酒石酸盐);性味功能:甘、温,补脾益气、养心安神;药理:有增强肌力的作用;主治:脾虚泄泻、心悸、失眠、盗汗、血小板减少性紫癜。
8.三七,别名:田七、滇七、参三七、汉三七,为五加科人参属植物三七(Panax Pseudoginseng Wall)的根块,是多年生草本,生于山坡丛林下,分布广西西南部、云南东南部、一般为栽培,江西、湖北及其他省也有栽培,其化学成分:块根含三七皂甙A(arasaponin A,C30H52O10)、三七皂甙B(arasaponin B,C23H38O10),二者水解后分别生成皂甙元A、皂甙元B及一分子葡萄糖,有五种三萜皂甙,其甙元为人参二醇和人参三醇,还含有生物碱和黄酮甙;性味功能:甘、微苦、温,活血祛瘀、止血、消肿止痛;药理:有止血、增加冠状动脉血流量、减慢心率、减少心肌氧消耗,能对抗因脑垂体后叶素所致的血压升高、冠状动脉收缩、预防和治疗关节炎的作用;主治:衄血、吐血、咯血、便血、跌打损伤。
9.十八症,别名:歪叶子兰、大肠风,为胡椒科胡椒属植物光轴苎叶蒟(Piperboehmeriaefolium Wall.Var.Lonkinense C.DC.,)以根或全株入药,是直立亚灌木或有时呈攀援状,生于密林下或山谷中,分布于广东及云南,其性味功能:辛、温,祛风散寒、散瘀止痛;主治:感冒、风湿筋骨痛、跌打肿痛、痛经、闭经、胃寒疼痛。
10.鸡内金,别名:鸡肫皮,为雉科动物鸡(Gallus gallus domesticus Brisson)的砂囊的角质内壁,全国各地(杀鸡后取肫)均有,其化学成分:主要由蛋白质构成,并含有胃激素(Ventriculin)等;性味功能:甘、平,健脾开胃、消食化积;药理:对胃液的分泌量、酸度及消化力均增高,对各种消化不良病疾有较满意的疗效;主治:消化不良、食欲不振、食积腹胀、小儿疳积、遗尿。
11.狗肾,是犬,别名:狗、家狗、地羊(Canis familiaris Linne)的雄性的生殖器(阴茎和睾丸),全国各地都有饲养,以广西和广东省较多,其性味功能:温、咸,入肾经、补肾、益精、温补壮阳;主治:阳痿、肾虚囊冷、遗泄和妇女痨疟身冷。
12.紫河东,别名:胎盘、衣胞、胎衣,为婴儿出生时胎盘的干燥品,全国各地妇产医院可收集到,其化学成分:含氮多糖体,由8分子的乙酰氨基葡萄糖(Nacelyl-D-glucosamine,C6H13O5N)、6分子的半乳糖(D-galactose)及6分子的甘露糖(mannose)所组成,并含有胨(peptone)、
(albumose)、多肽(polypeplide)、胆碱,新鲜胎盘含性腺激素(chorionic gonadotropin)、卵巢激素及黄体激素;性味功能:甘、咸、温,补气、养血、益精;药理:有促进乳腺和女性生殖器官发育、增强机体抵抗力,还有免疫及抗过敏的作用;主治:体质虚弱、贫血、虚喘、盗汗、神经衰弱、遗精、阳痿、不孕症、子宫肌炎。
13.甘草,别名:甜草根、红甘草、粉甘草、粉草,为豆科甘草属植物甘草(Glycyrrhiza Uralensis Fisch)的根和根状茎,是多年生草本,生于干燥草原及向阳山坡,分布于东北、华北及陕西、甘肃、青海、新疆、山东等地,其化学成分:根及根状茎含甘草甜素(glycyrrhizin),即甘草酸(glycyrrhinic acid,C42H62O16)6-14%,是一种三萜皂甙,水解产生一分子甘草次酸及二分子葡萄糖醛酸,并含少量甘草黄甙、异甘草黄甙、二羟基甘草次酸、甘草西定、甘草醇、异甘草醇和甘露醇、葡萄糖3.8%、蔗糖2.4-6.5%、苹果酸、桦木酸、天冬酰胺、菸酸、生活素296微克/克、微量挥发油等;性味功能:甘、平,清热解毒、润肺止咳、调理诸药、补脾益气;药理:有解毒、抗炎及抗变态反应、抗肝损伤、强心、抗癌等作用;主治:咽喉肿痛、咳嗽、脾胃虚弱、胃、十二指肠溃疡、肝炎、癔病、痈疖肿毒、药物及食物中毒。
14.抓鸡虎,又名:豹猫、喷鸡虎、花猫、平头狸、豹狸、斑猫、钱猫(Felisbengalensis Kerr),药用其骨骼,生活于郊野灌丛或村舍附近的树丛内,分布我国东北到华北,由甘肃、四川、云南到江苏、广东、广西各地都有,其性味功能:温、辛,祛风湿、滋补活血、强壮筋骨、镇心安神;主治:风湿关节疼痛、瘰疬。
15.菊花,别名:甘、白、黄甘、药、白茶、茶、怀、滁、毫,杭菊花,为菊科菊属植物菊花(Chrysanthemum morifolium Ramat)的花序,是多年生草本,全国各地都有栽培,其化学成分:花叶及茎均含挥发油,花中含量约0.13%,并含菊甙、腺嘌呤(adenine)、胆碱(choline)、水苏碱(stachydrine,C7H13O2N),还含有微量维生素A样物质、维生素B1、氨基酸及刺槐素等;性味功能:甘、凉,疏风散热、清肝明目、解疮毒;药理:对中枢神经有镇静作用,解热,使毛细血管抵抗力增强,抑菌:水煎及水浸剂对金黄色葡萄球菌、痢疾杆菌、变形杆菌、伤寒杆菌、副伤寒杆菌、霍乱孤菌、乙型溶血性链球菌、大肠杆菌、绿脓杆菌、人型结核杆菌及流感病毒(PR8株)均有抑制作用;主治:感胃风热、头痛、目赤、咽喉肿痛、头眩、耳鸣、疔疮肿毒。
二、本发明配方原料及系列产品的生产工艺:
1.以金樱子、黄芪、杜仲、枸杞子、木瓜、山楂、大枣、三七、十八症、鸡内金、狗肾、紫河车、甘草、抓鸡虎、菊花十五种天然植、动物中草药为主要配方原料制成药粉;
2.用1、的配方原料制成的药粉与酒基发酵(除涩增香),米酒浸泡,初滤,去单宁,加冰糖,精滤,消毒灌装得金樱健身酒成品;
3.用1、的配方原料制成的药粉与酒基发酵,置酒精、水上蒸馏,回收酒精,挥发残余酒精,无菌操作、过滤,消毒灌装得金樱健身液成品;
4.用1、的配方原料制成的药粉与酒基发酵,和蒸馏水搅拌,加白糖、柠檬酸、碳酸氢钠,过滤,消毒灌装得金樱保健饮料成品;
5.用1、的配方原料制成的药粉与水,熬浓汁、过滤,热浓缩,加砂糖、淀粉、山梨酸溶解后、消毒灌装得金樱保健膏成品;
6.用1、的配方原料制成的药粉与水,煎汁、过滤,热浓缩,加砂糖、山梨醇,干燥成粒、消毒袋泡滤纸包装得金樱保健速溶冲剂成品。
三、金樱保健系列产品及其制法的实施例:
1.以金樱子120克、黄芪120克、杜仲100克、枸杞子90克、木瓜90克、山楂60克、大枣60克、三七60克、十八症60克、鸡内金60克、狗肾60克、紫河车50克、甘草30克、抓鸡虎30克、菊花10克为主要配方原料制成药粉;
2.用1、的配方原料制成的药粉与酒基发酵(除涩增香),米酒浸泡,初滤,去单宁,加冰糖,精滤,消毒灌装制得金樱健身酒,其药粉、米酒、冰糖之配比为1∶30∶2.4,工艺中的酒基发酵15天,米酒浸泡10天(以下工艺与此同);
3.用1、的配方原料制成的药粉与酒基发酵,置食用酒精、水上蒸馏,回收酒精,挥发残余酒精,无菌操作、过滤,消毒灌装制得金樱健身液,其药粉、蒸馏水、食用酒精之配比为1∶25∶10,酒基发酵15天;
4.用1、的配方原料制成的药粉与酒基发酵,和蒸馏水搅拌,加白糖、柠檬酸、碳酸氢钠,过滤,消毒灌装制得金樱保健饮料,其药粉、蒸馏水、白糖、柠檬酸、碳酸氢钠之配比为1∶200∶12∶0.1∶0.1,酒基发酵15天;
5.用1、的配方原料制成的药粉与水,熬浓汁、过滤,热浓缩,加砂糖、淀粉、山梨醇,溶解后、消毒灌装制得金樱保健膏,其药粉、水、砂糖、淀粉、山梨醇之配比为1∶5∶0.5∶0.8∶0.002;
6.用1、的配方原料制成的药粉与水,煎汁、过滤,热浓缩,加砂糖、山梨醇,干燥成粒,消毒、袋泡滤纸包装制得金樱保健速溶冲剂,其药粉、水、砂糖、山梨醇之配比为1∶10∶8∶0.003。
由于本发明采用是纯天然植、动物中草药为主要配方原料,不含任何人工合成化合物,所制成的保健系列产品,富含多种营养成分、氨基酸、微量元素,具有保健、抗衰、益寿延年,防病、治病的作用,能治疗前列腺肥大并非细菌性炎、神经衰弱、脑动脉硬化、骨关节病、腰肌劳损等症。经食品卫生监督部门作急性毒性试验属实际无毒级,食品卫生检验结果:符合GB2757-81标准;分析测试部门用日立835-50氨基酸分析仪分析结果:含门冬氨酸等18种氨基酸,用JY70PⅡ-ICP,JP-2型示波极谱仪分析结果:含钙、铁、锰、锌、磷、硒微量元素,测试分析结果含SOD 502μ/100ml,并经医院临床统计,总有效率91.67%,是适合男女老少的理想保健品。
Claims (2)
1、金樱保健系列产品及其制法,包括:
1)、以用金樱子120克、黄芪120克、杜仲100克、枸杞子90克、木瓜90克、山楂60克、大枣60克、三七60克、十八症60克、鸡内金60克、狗肾60克、紫河车50克、甘草30克、抓鸡虎30克、菊花10克为主要配方原料制成药粉,
2)、用1)、的配方原料制成的药粉与酒基发酵,米酒浸泡,初滤,去单宁,加冰糖,精滤,消毒灌装制得金樱健身酒,其药粉、米酒、冰糖之配比为1∶30∶2.4,
3)、用1)、的配方原料制成的药粉与酒基发酵,置食用酒精、水上蒸馏,回收酒精,挥发残余酒精,无菌操作、过滤,消毒灌装制得金樱健身液,其药粉、蒸馏水、食用酒精之配比为1∶25∶10,
4)、用1)、的配方原料制成的药粉与酒基发酵,和蒸馏水搅拌,加白糖、柠檬酸、碳酸氢钠,过滤,消毒灌装制得金樱保健饮料,其药粉、蒸馏水、白糖、柠檬酸、碳酸氢钠之配比为1∶200∶12∶0.1∶0.1,
5)、用1)、的配方原料制成的药粉与水,熬浓汁、过滤,热浓缩,加砂糖、淀粉、山梨醇,溶解后、消毒灌装制得金樱保健膏,其药粉、水、砂糖、淀粉、山梨醇之配比为1∶5∶0.5∶0.8∶0.002,
6)、用1)、的配方原料制成的药粉与水,煎汁、过滤,热浓缩,加砂糖、山梨醇,干燥成粒,消毒、袋泡滤纸包装制得金樱保健速溶冲剂,其药粉、水、砂糖、山梨醇之配比为1∶10∶8∶0.003。
2、根据权利要求1所述的金樱保健系列产品及其制法,其特征在于工艺中的酒基发酵为15天,米酒浸泡为10天。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 94102409 CN1100949A (zh) | 1994-03-11 | 1994-03-11 | 金樱保健系列产品及其制法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 94102409 CN1100949A (zh) | 1994-03-11 | 1994-03-11 | 金樱保健系列产品及其制法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1100949A true CN1100949A (zh) | 1995-04-05 |
Family
ID=5030633
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 94102409 Pending CN1100949A (zh) | 1994-03-11 | 1994-03-11 | 金樱保健系列产品及其制法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1100949A (zh) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1050505C (zh) * | 1995-05-24 | 2000-03-22 | 胡文元 | 天然生物保健饮料的制作方法 |
| CN100396189C (zh) * | 2006-06-06 | 2008-06-25 | 孙健 | 养肝降脂果丹食品 |
| EP2036568A1 (en) * | 2007-09-12 | 2009-03-18 | Nestec S.A. | Wolfberries and inflammation |
| CN103666958A (zh) * | 2013-11-26 | 2014-03-26 | 廖智明 | 一种金樱子酒 |
| CN104099220A (zh) * | 2013-04-02 | 2014-10-15 | 廖少波 | 一种益寿延年保健药酒的配制方法 |
-
1994
- 1994-03-11 CN CN 94102409 patent/CN1100949A/zh active Pending
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1050505C (zh) * | 1995-05-24 | 2000-03-22 | 胡文元 | 天然生物保健饮料的制作方法 |
| CN100396189C (zh) * | 2006-06-06 | 2008-06-25 | 孙健 | 养肝降脂果丹食品 |
| EP2036568A1 (en) * | 2007-09-12 | 2009-03-18 | Nestec S.A. | Wolfberries and inflammation |
| WO2009034162A1 (en) * | 2007-09-12 | 2009-03-19 | Nestec S.A. | Wolfberries and inflammation |
| JP2010540415A (ja) * | 2007-09-12 | 2010-12-24 | ネステク ソシエテ アノニム | ウルフベリー及び炎症 |
| US9072769B2 (en) | 2007-09-12 | 2015-07-07 | Nestec S.A. | Wolfberries and skin inflammation |
| CN104099220A (zh) * | 2013-04-02 | 2014-10-15 | 廖少波 | 一种益寿延年保健药酒的配制方法 |
| CN103666958A (zh) * | 2013-11-26 | 2014-03-26 | 廖智明 | 一种金樱子酒 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103906526B (zh) | 利用药用花的包裹发酵方法及利用其的皮肤外用剂组合物 | |
| CN101695376B (zh) | 预防糖尿病的保健食品 | |
| CN102511867B (zh) | 红枣阿胶枸杞浓浆及其生产工艺 | |
| CN105695258A (zh) | 一种含荔枝核皂苷的女性保健酒 | |
| KR20160119999A (ko) | 동의보감 원문에 근거한 국산 유기농 공진단 및 이의 제조방법 | |
| CN105454576A (zh) | 茉莉花八宝茶及其制备方法 | |
| CN106937741A (zh) | 一种脱脂亚麻籽粉防癌抗癌健康减肥法及其制备方法 | |
| CN113144168A (zh) | 鹿鞭丸的制作方法 | |
| CN103520302B (zh) | 一种沙棘叶抗疲劳胶囊及其制备方法 | |
| CN103550721B (zh) | 具有降压安眠功效的中药组合物及含有该组合物的药枕 | |
| CN106265438A (zh) | 中药杏仁美容面膜 | |
| CN114099626A (zh) | 一种用于人体保健的多功能组合物及其制备方法与用途 | |
| CN114404517A (zh) | 一种用于痛风和降低尿酸的组合物及其用途与制备方法 | |
| CN108887544A (zh) | 一种天然养生饮料 | |
| KR20160000695A (ko) | Dha 함유 기억력 강화 및 피로회복 증진용 한약재 조성물 수능환 및 그 제조방법 | |
| CN1100949A (zh) | 金樱保健系列产品及其制法 | |
| CN1114892A (zh) | 神灵茶 | |
| CN106434251A (zh) | 一种加入保健药材的醋曲块 | |
| KR101783549B1 (ko) | Dha 함유 피로회복 증진 보조식품용 조성물 수능단(수능원) 및 그 제조방법 | |
| CN102764394A (zh) | 治疗生殖性疾病的化毒和菌中药组合物及其制备方法 | |
| CN106367297A (zh) | 一种用于晒醋的醋曲块 | |
| CN113384661A (zh) | 一种解酒组合物及其制备方法 | |
| CN114246924A (zh) | 松柏保健膏 | |
| CN114748583A (zh) | 一种滋补养生的中药药酒 | |
| CN113018398A (zh) | 一种抗疲劳保健品及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C01 | Deemed withdrawal of patent application (patent law 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |